Institution
University of Ljubljana
Education•Ljubljana, Slovenia•
About: University of Ljubljana is a education organization based out in Ljubljana, Slovenia. It is known for research contribution in the topics: Population & Liquid crystal. The organization has 17210 authors who have published 47013 publications receiving 1082684 citations. The organization is also known as: Univerza v Ljubljani.
Papers published on a yearly basis
Papers
More filters
••
Université catholique de Louvain1, University of Turin2, University of Florida3, Joint Institute for Nuclear Research4, Durham University5, University College London6, CERN7, Karlsruhe Institute of Technology8, Lawrence Berkeley National Laboratory9, Michigan State University10, University of Ljubljana11, Dresden University of Technology12, ETH Zurich13, University of Manchester14, University of Cambridge15
TL;DR: A standard file format is proposed to store process and event information, primarily output from parton-level event generators for further use by general-purpose ones.
469 citations
••
TL;DR: Evaluation of the antibacterial activity of plant extracts is suggested using the broth microdilution method as a fast screening method for MIC determination and the macrodilutions method at selected MIC values to confirm bacterial inactivation.
469 citations
••
Serbian Academy of Sciences and Arts1, Wrocław Medical University2, Charité3, Hannover Medical School4, Robertson Centre for Biostatistics5, National Institutes of Health6, University Medical Center Groningen7, Tel Aviv University8, Rabin Medical Center9, Queen's University Belfast10, University of Ljubljana11, Technion – Israel Institute of Technology12, University of Cambridge13, University of Brescia14, University of Zagreb15, University of London16, University of Cyprus17, National and Kapodistrian University of Athens18
TL;DR: This expert consensus report is neither a guideline update nor a position statement, but rather a summary and consensus view in the form of consensus recommendations.
Abstract: The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) over the last 25 years, most recently in 2016. Given the amount of new information that has become available since then, the Heart Failure Association (HFA) of the ESC recognized the need to review and summarise recent developments in a consensus document. Here we report from the HFA workshop that was held in January 2019 in Frankfurt, Germany. This expert consensus report is neither a guideline update nor a position statement, but rather a summary and consensus view in the form of consensus recommendations. The report describes how these guidance statements are supported by evidence, it makes some practical comments, and it highlights new research areas and how progress might change the clinical management of HF. We have avoided re-interpretation of information already considered in the 2016 ESC/HFA guidelines. Specific new recommendations have been made based on the evidence from major trials published since 2016, including sodium-glucose co-transporter 2 inhibitors in type 2 diabetes mellitus, MitraClip for functional mitral regurgitation, atrial fibrillation ablation in HF, tafamidis in cardiac transthyretin amyloidosis, rivaroxaban in HF, implantable cardioverter-defibrillators in non-ischaemic HF, and telemedicine for HF. In addition, new trial evidence from smaller trials and updated meta-analyses have given us the chance to provide refined recommendations in selected other areas. Further, new trial evidence is due in many of these areas and others over the next 2 years, in time for the planned 2021 ESC guidelines on the diagnosis and treatment of acute and chronic heart failure.
467 citations
••
Wouter van Rheenen1, Aleksey Shatunov2, Annelot M. Dekker1, Russell L. McLaughlin3 +184 more•Institutions (54)
TL;DR: Evidence of ALS being a complex genetic trait with a polygenic architecture is established and the SNP-based heritability is estimated at 8.5%, with a distinct and important role for low-frequency variants (frequency 1–10%).
Abstract: To elucidate the genetic architecture of amyotrophic lateral sclerosis (ALS) and find associated loci, we assembled a custom imputation reference panel from whole-genome-sequenced patients with ALS and matched controls (n = 1,861). Through imputation and mixed-model association analysis in 12,577 cases and 23,475 controls, combined with 2,579 cases and 2,767 controls in an independent replication cohort, we fine-mapped a new risk locus on chromosome 21 and identified C21orf2 as a gene associated with ALS risk. In addition, we identified MOBP and SCFD1 as new associated risk loci. We established evidence of ALS being a complex genetic trait with a polygenic architecture. Furthermore, we estimated the SNP-based heritability at 8.5%, with a distinct and important role for low-frequency variants (frequency 1-10%). This study motivates the interrogation of larger samples with full genome coverage to identify rare causal variants that underpin ALS risk.
466 citations
••
TL;DR: In this article, a comprehensive review of physics effects generated by leptoquarks (LQs), i.e., hypothetical particles that can turn quarks into leptons and vice versa, of either scalar or vector nature, is presented.
464 citations
Authors
Showing all 17388 results
Name | H-index | Papers | Citations |
---|---|---|---|
David Miller | 203 | 2573 | 204840 |
Hyun-Chul Kim | 176 | 4076 | 183227 |
James M. Tour | 143 | 859 | 91364 |
Carmen García | 139 | 1503 | 96925 |
Bernt Schiele | 130 | 568 | 70032 |
Vladimir Cindro | 129 | 1157 | 82000 |
Teresa Barillari | 129 | 984 | 78782 |
Sven Menke | 129 | 1121 | 82034 |
Horst Oberlack | 129 | 985 | 80069 |
Hubert Kroha | 129 | 1126 | 80746 |
Peter Schacht | 129 | 1030 | 80092 |
Siegfried Bethke | 129 | 1266 | 103520 |
Igor Mandić | 128 | 1065 | 79498 |
Stefan Kluth | 128 | 1261 | 84534 |
Andrej Gorišek | 128 | 951 | 67830 |